α
AlphaScala
StocksSignalsNEWAlpha ScoreBriefingsNEWBrokers
Sign InGet Started
α
AlphaScala

Professional trading analysis with publicly tracked portfolios on TipRanks. Real trades, real data.

Markets

ForexStocksCryptoCommodities

Tools

Stock ResearchMarket SignalsMarket BriefingsAlpha ScoreHedge Funds 13FInsider BuysPolitician TradesAgentic TradingAI Broker MatcherBroker ReviewsPortfoliosFree IndicatorsBlogLearn TradingTrading Q&A

Account

Sign InDashboardNewsletterContact UsAdvertise

Legal

AboutMethodologyEditorial PolicyCorrectionsTerms of ServicePrivacy PolicyRisk Disclaimer

Risk Warning: AlphaScala provides educational content only and is not a financial advisor. Trading and investing involves substantial risk of loss and is not suitable for all investors. Past performance does not guarantee future results. You should consult a licensed financial advisor before making investment decisions. See our full risk disclaimer.

© 2026 ROGA AI LIMITED · Registered in Gibraltar · Unit G02, Eurocity, Europort Avenue, Gibraltar GX11 1AAAlphaScala – Built with data, not hype.

Market Analysis

Opinionated, data-backed coverage across all asset classes

AllForexStocksCryptoCommoditiesIndices
Alkane Finds New High-Grade Zone at Costerfield Gold Mine
Commodities5d ago

Alkane Finds New High-Grade Zone at Costerfield Gold Mine

Alkane Resources discovered a new high-grade zone at its Costerfield gold-antimony mine in Victoria, with intercepts including 1,360 g/t gold at Cuffley and ore-grade hits at the Sub-KC domain.

Walmart's Scenario Apparel Targets Amazon's Fashion Share
Stocks5d ago

Walmart's Scenario Apparel Targets Amazon's Fashion Share

Walmart launches Scenario apparel brand with most items under $25, targeting younger shoppers and Amazon's fashion share as CEO cites consumer pressure from higher fuel costs.

Crypto markets pause, AI trading tools face tougher questions
Crypto5d ago

Crypto markets pause, AI trading tools face tougher questions

Saturday's crypto session lacked a catalyst, leaving traders focused on AI trading tools. The easy hype phase is fading as transparency becomes the real differentiator.

Bitcoin Faces PCE, GDP, Jobs Data in Heavy US Data Week
Crypto5d ago

Bitcoin Faces PCE, GDP, Jobs Data in Heavy US Data Week

Bitcoin faces a heavy week of US data with July PCE inflation, revised Q2 GDP, and jobless claims all due. The prints will test whether the recent rally can hold.

OpenAI's Lehane Warns of Persistent AI Cyberattacks
Stocks5d ago

OpenAI's Lehane Warns of Persistent AI Cyberattacks

OpenAI's Chris Lehane told The Guardian that open-source models will enable persistent AI-driven attacks. The warning follows a July incident where OpenAI agents hacked Hugging Face.

El Niño, China Gold Buying, Silver Breakout, Trump Tantrum
Commodities5d ago

El Niño, China Gold Buying, Silver Breakout, Trump Tantrum

China quietly bought 88 tonnes of gold OTC in May-June, 4x official. Silver breaks multi-year downtrend. Ag at decade high. Trump suggests military for bond yields. Hard assets rally.

Novo Nordisk Deepens AWS AI Tie-Up to Speed Drug Discovery
Stocks5d ago

Novo Nordisk Deepens AWS AI Tie-Up to Speed Drug Discovery

Novo Nordisk expanded its AI deal with AWS to speed drug discovery. The company aims to have an AI-designed drug in human trials by 2026 as big pharma races for compute and talent.

Diablo Resources Readies Drilling at Utah Silver Targets
Commodities5d ago

Diablo Resources Readies Drilling at Utah Silver Targets

Diablo Resources completes earthworks at Star Range, preps five-hole diamond drill program, and advances reconnaissance at Horn Silver in Utah.

FAO Warns Fertilizer Crisis to Tighten Food Supply Into 2027
Stocks5d ago

FAO Warns Fertilizer Crisis to Tighten Food Supply Into 2027

FAO warns fertilizer disruptions from the Strait of Hormuz will reduce crop yields and tighten food supplies through 2027, as Ukraine's grain exports collapse and a record Super El Niño looms.

Gilead’s HIV Business is Surging, but is the Company Too Dependent on One Franchise?
Stocks5d ago

Gilead’s HIV Business is Surging, but is the Company Too Dependent on One Franchise?

Gilead's Q2 revenue rose 10% to $7.8B, driven by HIV products that now account for 75% of sales. Yeztugo shows promise, but oncology lags. Alpha Score 40.

Helcim Raises $38 Million to Fill Small Business Banking Void
Stocks5d ago

Helcim Raises $38 Million to Fill Small Business Banking Void

Helcim raises $38M as Canadian banks exit merchant services, creating a void. CEO Nic Beique says the round lets the payments firm scale up-market and add credit union partnerships.

Pfizer's Patent Cliff: Can New Drugs Offset $1.1B Annual Hit?
Stocks5d ago

Pfizer's Patent Cliff: Can New Drugs Offset $1.1B Annual Hit?

Pfizer's Q2 non-COVID revenue grew 5% operationally, but patent expirations on Eliquis, Ibrance, and Xtandi threaten $1.1B annual revenue. Can new drugs fill the gap?

Load More
Recently Updated
AAPL
319.70+1.63%
MSFT
513.53+1.68%
NVDA
217.55-4.57%
AMZN
266.43+3.97%
GOOGL
346.59+1.74%
META
578.02+1.21%
TSLA
348.75-1.71%
JPM
357.62+0.96%
Quick Stats
S&P 500
0.12-4.17%
Browse by Market
ForexStocksCryptoCommodities
Asset Profiles
Bitcoin (BTC)Apple (AAPL)EUR/USDGoldEthereum (ETH)NVIDIA (NVDA)
Trading Q&A
Browse all questions ->